has dropped to 50% from its peak after ranbaxy deal. now ranbaxys gain is daiichis n hence ranbaxy cann`t go back to 270 levels! further, loyalful investors of ranbaxy r going to cash rich in two days...who will turn to buy more at cmp or on every fall! - gupta....

atleast if not more! open offer is going to be accepted soon, investors who hv tendered for open offer will be cash rich n will certainly look to add more as ranbaxy is not supplying medicines to us alone. further usfda not at given final verdict! omagine incase of a positive verdict where shorts will stand! - tks n regds - gupta....

Dear Friend, I dont agree with you fully, becoz having watched the volotility and risk all previous Ranbaxy Share Holders would invest in other companies which are going cheap. There is rumour that Daiichi would delist these shares in Indian Stock Exch. All Investors whose shares were not purchased by Daichi becoz of oversubscription would jump to sell the shares in Open Market from wednesday onwards which could increase selling pressure. Vijay...